Medidata Solutions Inc Forecasted to Post FY2018 Earnings of $0.82 Per Share (MDSO)

Medidata Solutions Inc (NASDAQ:MDSO) – Stock analysts at KeyCorp decreased their FY2018 earnings per share (EPS) estimates for shares of Medidata Solutions in a note issued to investors on Sunday, November 18th. KeyCorp analyst D. Hooker now forecasts that the company will post earnings per share of $0.82 for the year, down from their prior forecast of $0.83.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings data on Thursday, October 18th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.06. The business had revenue of $163.41 million during the quarter, compared to analysts’ expectations of $162.09 million. Medidata Solutions had a return on equity of 10.70% and a net margin of 8.43%. The business’s quarterly revenue was up 17.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.33 EPS.

Several other brokerages have also recently issued reports on MDSO. ValuEngine upgraded Medidata Solutions from a “hold” rating to a “buy” rating in a research note on Friday, August 24th. BidaskClub upgraded Medidata Solutions from a “buy” rating to a “strong-buy” rating in a research note on Thursday, August 16th. Royal Bank of Canada decreased their target price on Medidata Solutions to $91.00 and set an “outperform” rating for the company in a research note on Tuesday, September 25th. Piper Jaffray Companies decreased their target price on Medidata Solutions from $96.00 to $93.00 in a research note on Thursday, October 18th. Finally, JPMorgan Chase & Co. decreased their target price on Medidata Solutions to $74.00 and set a “neutral” rating for the company in a research note on Friday, October 19th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $84.64.

Shares of MDSO opened at $72.91 on Wednesday. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.52 and a quick ratio of 2.52. The stock has a market capitalization of $4.39 billion, a PE ratio of 85.78, a P/E/G ratio of 4.25 and a beta of 1.30. Medidata Solutions has a 1 year low of $59.60 and a 1 year high of $88.87.

A number of hedge funds have recently bought and sold shares of the stock. Man Group plc purchased a new stake in Medidata Solutions in the third quarter valued at approximately $205,000. World Asset Management Inc purchased a new stake in Medidata Solutions in the second quarter valued at approximately $235,000. Zeke Capital Advisors LLC purchased a new stake in Medidata Solutions in the second quarter valued at approximately $239,000. First Republic Investment Management Inc. purchased a new stake in Medidata Solutions in the second quarter valued at approximately $242,000. Finally, Quantbot Technologies LP purchased a new stake in Medidata Solutions in the third quarter valued at approximately $229,000.

In related news, EVP Michael I. Otner sold 7,030 shares of the business’s stock in a transaction that occurred on Tuesday, October 23rd. The stock was sold at an average price of $69.40, for a total transaction of $487,882.00. Following the completion of the sale, the executive vice president now owns 62,548 shares in the company, valued at $4,340,831.20. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 4.70% of the stock is owned by insiders.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

Recommended Story: Do You Need a Fiduciary?

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply